References
- Sun Z, Andersson R. NF-kappaB activation and inhibition: a review. Shock 2002; 18: 99–106
- Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004; 6: 203–8
- Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, Meier JJ, et al. Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis. Oncology 2003; 65: 37–45
- Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, et al. Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery 2001; 130: 363–9
- Beg AA, Sha WC, Bronson RT, Baltimore D. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev 1995; 9: 2736–46
- Jungnickel B, Staratschek-Jox A, Brauninger A, Spieker T, Wolf J, Diehl V, et al. Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 2000; 191: 395–402
- Scaife CL, Kuang J, Wills JC, Trowbridge DB, Gray P, Manning BM, et al. Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: implications for metastasis. Cancer Res 2002; 62: 6870–8
- Hochwald SN, Lind DS, Malaty J, Copeland EM 3rd, Moldawer LL, Mackay SL. Antineoplastic therapy in colorectal cancer through protease inhibition. Am J Surg 2003; 69: 15–23
- Ross JS, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP, Jr, Kaur P, et al. Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence. Clin Cancer Res 2004; 10: 2466–72
- Ito CY, Adey N, Bautch VL, Baldwin AS, Jr. Structure and evolution of the human IKBA gene. Genomics 1995; 29: 490–5
- Conne B, Stutz A, Vassalli JD. The 3′ untranslated region of messenger RNA: a molecular “hotspot” for pathology?. Nat Med 2000; 6: 637–41
- Glavac D, Ravnik-Glavac M, O'Brien SJ, Dean M. Polymorphisms in the 3′ untranslated region of the I kappa B/MAD-3 (NFKBI) gene located on chromosome 14. Hum Genet 1994; 93: 694–6
- Parker KM, Ma MH, Manyak S, Altamirano CV, Tang YM, Frantzen M, et al. Identification of polymorphisms of the IkappaBalpha gene associated with an increased risk of multiple myeloma. Cancer Genet Cytogenet 2002; 137: 43–8
- Curran JE, Weinstein SR, Griffiths LR. Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 2002; 188: 103–7
- Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen JT, et al. A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis 2004; 19: 153–6
- Bessenyei B, Marka M, Urban L, Zeher M, Semsei I. Single nucleotide polymorphisms: aging and diseases. Biogerontology 2004; 5: 291–303